Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists diagnose and manage melanoma more effectively than general practitioners.

There is no significant link between alopecia areata and the PON1 enzyme polymorphisms studied.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The study developed a tool to predict how gut microbes process foods and drugs, showing that similar compounds often share metabolic pathways and effects.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Low PON1 levels may indicate and predict the severity of hair loss.

Using a gel called Diclofenac can potentially cause hair to grow back in bald spots in older men.

Chromosomal differences affect how muscle cells respond to testosterone.

Some plants like spinach, broccoli, and matcha may boost the effectiveness of the hair growth drug minoxidil.

Cell-based models help test if cosmetic ingredients really work for hair growth and skin health.

Vegan collagen builder improves hair growth, skin smoothness, and reduces wrinkles and pain.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Scalp hair follicle culture has limits for testing minoxidil's hair growth effects.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

The enzyme Rand protease works well for leather dehairing and its stability is important, with Leu75 playing a key role.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

Finasteride affects UGT1A4 enzyme, but not enough to cause issues when combined with other drugs.

New nanoparticles deliver plant extracts to hair follicles to treat conditions like hair loss and acne.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

The document concludes that current hair loss treatments have limitations and suggests researching new treatments targeting different factors of hair loss.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.